Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation to introduce various cardiovascular catheters ...

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried out using its device ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and ...

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has submitted a 510(k) premarket ...

Transseptal Solutions, developer of a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation to treat multiple clinical indications, has received its first ...

The occurrence of acute brain lesions was lower with a transseptal puncture than with a conventional retrograde aortic approach in patients undergoing left ventricular catheter ablation, with no ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Physicians with limited experience closing the left atrial appendage (LAA) with the Watchman device (Boston Scientific) in patients with atrial fibrillation do not appear to have worse clinical ...

CLEVELAND, March 1, 2011 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation technology, is happy to announce the release of their new ...

The US Food and Drug Administration has cleared the AcQCross family of universal transseptal crossing devices, Acutus Medical announced today. "This is the first and only transseptal puncture system ...